SOCS2 is also recognized as a tumor suppressor because reduced expression upon hypermethylation is associated with activation of STAT3 in ovarian and breast cancers, indicating increased cytokine responsiveness in tumors26. This evidence concerns the gene STAT3 and breast carcinoma.